FARMAMONDO INNOVATIVE THERAPIES

We are a fast-growing Swiss based pharmaceutical group providing access to specialty medicines to doctors and hospitals, through a unique service and geographical footprint, in more than 80 markets.

We provide oncologists, paediatric oncologists and rare disease specialists with Managed Access Programs (MAPs) around the globe, wherever innovative treatments are not commercially available.

We have active MAPs in Russia, Commonwealth of Independent States, India, Asia, Latin America, Middle East and Africa. Note that the availability of MAPs is decided country by country, based on strict criteria such as agreements with the manufacturer, IP rights, and might not be available across each region.

Our Managed Access Programs (often called Named Patient Programs) service gives access to the Physicians and Hospitals the possibility to treat patients with innovative FDA or EMA approved medicines which are not commercially available in their home countries. To cover these unmet medical needs, most countries have put in place specific pathways to give access to and finance these unapproved but life-saving treatments for eligible patients.

FarmaMondo has extremely high standards of quality and compliance to protect the physicians and the patients and make sure that the patients treated are served in the long term.

FarmaMondo is constantly in contact with manufacturers to discuss ways to extend MAPs to new therapies.
Should you wish to stay informed, please leave us your details by clicking here.
Please let us know your fields of interest.